Ding Yu
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Inflammatory Biomarkers in Disease Prognosis
-
- COVID-19 epidemiological studies
Papers in
- Genetics 2
- Myeloproliferative Neoplasms: Diagnosis and Treatment 2
-
- Long-Term Effects of COVID-19 2
- Co-authors
- Huichuan Yang (1 shared paper)Dongkun Zhang (2 shared papers)Guibin Qiao (2 shared papers)Haiyu Zhou (2 shared papers)Sichao Wang (2 shared papers)Dan Tian (2 shared papers)Xiaoming Yang (1 shared paper)Jiming Tang (2 shared papers)
- Journals
- Annals of Translational Medicine (2 papers)European Journal of Pharmacology (1 paper)Blood (1 paper)Depression and Anxiety (1 paper)MedComm (1 paper)
- Partner nations
- China
In The Last Decade
Ding Yu
5 papers receiving 24 citations
Peers
Comparison fields: 5 of 19
- Oncology 6
- Modeling and Simulation 1
- Pulmonary and Respiratory Medicine 6
- Information Systems and Management 1
- Complementary and alternative medicine 1
Countries citing papers authored by Ding Yu
This map shows the geographic impact of Ding Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ding Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ding Yu more than expected).
Fields of papers citing papers by Ding Yu
This network shows the impact of papers produced by Ding Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ding Yu. The network helps show where Ding Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ding Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 11 | |
| 2 | 2021 | 6 | |
| 3 | 2023 | 4 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 1 | |
| 6 | 2025 | 0 |
About Ding Yu
Ding Yu is a scholar working on Genetics, Neurology, Rheumatology, Hematology and Infectious Diseases, having authored 6 papers that have together received 24 indexed citations. Recurring topics across this work include Long-Term Effects of COVID-19 (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Chronic Myeloid Leukemia Treatments (2 papers), Eosinophilic Disorders and Syndromes (2 papers), Healthcare professionals’ stress and burnout (1 paper), COVID-19 Clinical Research Studies (1 paper), COVID-19 and Mental Health (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). The work is most often cited by research in Oncology (6 citations), Modeling and Simulation (1 citation), Pulmonary and Respiratory Medicine (6 citations), Information Systems and Management (1 citation) and Complementary and alternative medicine (1 citation). Ding Yu has collaborated with scholars based in China. Frequent co-authors include Huichuan Yang, Dongkun Zhang, Guibin Qiao, Haiyu Zhou, Sichao Wang, Dan Tian, Xiaoming Yang, Jiming Tang, Zihao Zhou and Ruiqing Shi. Their work appears in journals such as Annals of Translational Medicine, European Journal of Pharmacology, Blood, Depression and Anxiety and MedComm.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.